Approvals/CIMA-AEMPS/OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA COMBIX 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA COMBIX 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Laboratorios Combix S.L.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 17870c1cbf2b00d4
Drug Cima Aemps Name: OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA COMBIX 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86302
Holder Company Name: Laboratorios Combix S.L.U.
Marketing Company Name: Laboratorios Combix S.L.U.
Authorization Date: 2021-10-07
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 20 mg/5 mg/12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Laboratorios Combix S.L.U.

OLMESARTAN MEDOXOMILO

20 mg

AMLODIPINO BESILATO

6,9 mg

HIDROCLOROTIAZIDA

12,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 7, 2021

Approval ID

17870c1cbf2b00d4

Type

Standard